Launch week offerEnds in00h00m00s

Michael W. Parker

Country flagAustralia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (13)

Year:

2026

Year:

2026

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

The cholesterol‐dependent cytolysins (CDCs) are a major family of bacterial pore‐forming proteins secreted as virulence factors by Gram‐positive bacterial species. CDCs are produced as soluble, monomeric proteins that bind specifically to cholesterol‐rich membranes, where they oligomerize into ring‐shaped pores of more than 30 monomers. Understanding the details of the steps the toxin undergoes in converting from monomer to a membrane‐spanning pore is a continuing challenge. In this review we summarize what we know about CDCs and highlight the remaining outstanding questions that require answers to obtain a complete picture of how these toxins kill cells.

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Leann Tilley

University of Melbourne

AUSTRALIA
View details

Till Böcking

Professor

University of New South Wales

AUSTRALIA
View details

Kanta Subbarao

Professor

University of Melbourne

AUSTRALIA
View details

Gary Anderson

University of Melbourne

AUSTRALIA
View details

Pascal Duijf

Associate Professor

University of South Australia

AUSTRALIA
View details

Hui K. Gan

La Trobe University

AUSTRALIA
View details

Steffen U Eisenhardt

Chief

University Medical Center Freiburg

GERMANY
View details

Justin P Hardee

University of Florida

UNITED STATES
View details

Karlheinz Peter

MONASH UNIVERSITY

AUSTRALIA
View details

Savio George Barreto

Flinders University

AUSTRALIA
View details

Claudine S. Bonder

Professor in Cancer Biology

University of South Australia

AUSTRALIA
View details

James Walsh

UNSW Sydney

AUSTRALIA
View details

Eric Hanssen

Professor

University of Melbourne

AUSTRALIA
View details

Michael Griffin

University of Melbourne

AUSTRALIA
View details

Jon Oakhill

Group Head

St Vincent's Institute of Medical Research

AUSTRALIA
View details